Sibylle Bischofberger Frick

Sibylle Bischofberger Frick is a seasoned equity research analyst specializing in Medical Technology and Specialty Chemicals, currently serving as a Senior Equity Research Analyst at Vontobel since October 2020. With extensive experience spanning over two decades in the field, Sibylle previously held senior analyst positions at Zürcher Kantonalbank and Credit Suisse, focusing on life sciences, biotech, and chemicals. Sibylle has a strong track record of conducting primary and secondary research, engaging with top management and clients, and publishing studies and analyses on industry trends. Academic credentials include a Master of Science from ETH Zürich in biochemistry and biotechnology, and a Master of Arts in Business Administration from the University of Zurich. Sibylle also has experience as a business consultant at Arthur Andersen Business Consulting.